Close

Amgen (AMGN): Phase 3 romosozumab Answers Some Questions - BMO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. INFY
3. ISRG
4. SPY
5. JWN
6. TSM
7. SLB
8. PPG
9. PARA
10. PG


Go back to Amgen (AMGN): Phase 3 romosozumab Answers Some Questions - BMO
Amgen Inc (NASDAQ: AMGN) Delayed: 262.75 --0 (-0%)
Previous Close $262.75    52 Week High $176.85 
Open $262.75    52 Week Low $133.64 
Day High $262.75    P/E 39.57 
Day Low $262.75    EPS $6.64 
Volume 297